Your browser doesn't support javascript.
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia.
García-García, Ana; Pérez de Diego, Rebeca; Flores, Carlos; Rinchai, Darawan; Solé-Violán, Jordi; Deyà-Martínez, Àngela; García-Solis, Blanca; Lorenzo-Salazar, José M; Hernández-Brito, Elisa; Lanz, Anna-Lisa; Moens, Leen; Bucciol, Giorgia; Almuqamam, Mohamed; Domachowske, Joseph B; Colino, Elena; Santos-Perez, Juan Luis; Marco, Francisco M; Pignata, Claudio; Bousfiha, Aziz; Turvey, Stuart E; Bauer, Stefanie; Haerynck, Filomeen; Ocejo-Vinyals, Javier Gonzalo; Lendinez, Francisco; Prader, Seraina; Naumann-Bartsch, Nora; Pachlopnik Schmid, Jana; Biggs, Catherine M; Hildebrand, Kyla; Dreesman, Alexandra; Cárdenes, Miguel Ángel; Ailal, Fatima; Benhsaien, Ibtihal; Giardino, Giuliana; Molina-Fuentes, Agueda; Fortuny, Claudia; Madhavarapu, Swetha; Conway, Daniel H; Prando, Carolina; Schidlowski, Laire; Martínez de Saavedra Álvarez, María Teresa; Alfaro, Rafael; Rodríguez de Castro, Felipe; Meyts, Isabelle; Hauck, Fabian; Puel, Anne; Bastard, Paul; Boisson, Bertrand; Jouanguy, Emmanuelle; Abel, Laurent.
  • García-García A; Pediatric Allergy and Clinical Immunology Dept., Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona , Barcelona, Spain.
  • Pérez de Diego R; Study Group for Immune Dysfunction Diseases in Children, Institut de Recerca Sant Joan de Déu, Barcelona , Barcelona, Spain.
  • Flores C; Clinical Immunology Unit, Hospital Sant Joan de Déu-Hospital Clínic Barcelona , Barcelona, Spain.
  • Rinchai D; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz Hospital , Madrid, Spain.
  • Solé-Violán J; Genomics Division, Instituto Tecnológico y de Energías Renovables , Santa Cruz de Tenerife, Spain.
  • Deyà-Martínez À; Research Unit, Hospital Universitario N.S. de Candelaria , Santa Cruz de Tenerife, Spain.
  • García-Solis B; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III , Madrid, Spain.
  • Lorenzo-Salazar JM; Dept. of Clinical Sciences, University Fernando Pessoa Canarias , Las Palmas de Gran Canaria, Spain.
  • Hernández-Brito E; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University , New York, NY, USA.
  • Lanz AL; CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III , Madrid, Spain.
  • Moens L; Dept. of Clinical Sciences, University Fernando Pessoa Canarias , Las Palmas de Gran Canaria, Spain.
  • Bucciol G; Dept. of Intensive Care Medicine, University Hospital of Gran Canaria Dr. Negrin, Canarian Health System , Las Palmas de Gran Canaria, Spain.
  • Almuqamam M; Pediatric Allergy and Clinical Immunology Dept., Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona , Barcelona, Spain.
  • Domachowske JB; Study Group for Immune Dysfunction Diseases in Children, Institut de Recerca Sant Joan de Déu, Barcelona , Barcelona, Spain.
  • Colino E; Clinical Immunology Unit, Hospital Sant Joan de Déu-Hospital Clínic Barcelona , Barcelona, Spain.
  • Santos-Perez JL; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, La Paz Hospital , Madrid, Spain.
  • Marco FM; Genomics Division, Instituto Tecnológico y de Energías Renovables , Santa Cruz de Tenerife, Spain.
  • Pignata C; Dept. of Immunology, University Hospital of Gran Canaria Dr. Negrin, Canarian Health System , Las Palmas de Gran Canaria, Spain.
  • Bousfiha A; Dept. of Pediatrics, Division of Pediatric Immunology and Rheumatology, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität München , Munich, Germany.
  • Turvey SE; Laboratory for Inborn Errors of Immunity, Dept. of Microbiology, Immunology and Transplantation KU Leuven , Leuven, Belgium.
  • Bauer S; Laboratory for Inborn Errors of Immunity, Dept. of Microbiology, Immunology and Transplantation KU Leuven , Leuven, Belgium.
  • Haerynck F; Dept. of Pediatrics, Childhood Immunology, UZ Leuven , Leuven, Belgium.
  • Ocejo-Vinyals JG; Dept. of Pediatrics, Drexel University College of Medicine, St Christopher's Hospital for Children , Philadelphia, PA, USA.
  • Lendinez F; Dept. of Pediatrics, SUNY Upstate Medical University , Syracuse, NY, USA.
  • Prader S; Unidad de Enfermedades Infecciosas, Complejo Hospitalario Universitario Insular-Materno Infantil , Las Palmas de Gran Canaria, Spain.
  • Naumann-Bartsch N; Unidad de Gestión Clínica de Pediatría y Cirugía Pediátrica, Hospital Virgen de las Nieves-IBS , Granada, Spain.
  • Pachlopnik Schmid J; Dept. of Immunology, Alicante University General Hospital Doctor Balmis , Alicante, Spain.
  • Biggs CM; Alicante Institute for Health and Biomedical Research , Alicante, Spain.
  • Hildebrand K; Dept. of Translational Medical Sciences, Section of Pediatrics, Federico II University , Naples, Italy.
  • Dreesman A; Dept. of Pediatric Infectious Diseases and Clinical Immunology, Ibn Rushd University Hospital , Casablanca, Morocco.
  • Cárdenes MÁ; Clinical Immunology, Autoimmunity and Inflammation Laboratory, Faculty of Medicine and Pharmacy, Hassan II University , Casablanca, Morocco.
  • Ailal F; Dept. of Paediatrics, BC Children's Hospital, University of British Columbia , Vancouver, Canada.
  • Benhsaien I; Clinic for Children and Adolescents. Dept. of Hematology and Oncology. University Clinic Erlangen , Erlangen, Germany.
  • Giardino G; Dept. of Pediatric Immunology and Pulmonology, Centre for Primary Immune Deficiency Ghent, Ghent University Hospital , Ghent, Belgium.
  • Molina-Fuentes A; Dept. of Internal Medicine and Pediatrics, PID Research Laboratory, Ghent University , Ghent, Belgium.
  • Fortuny C; Dept. of Immunology, University Hospital Marqués de Valdecilla, IDIVAL , Santander, Spain.
  • Madhavarapu S; Dept. of Pediatric Oncohematology, Hospital Materno Infantil Torrecárdenas , Almería, Spain.
  • Conway DH; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; University of Zurich , Zurich, Switzerland.
  • Prando C; Clinic for Children and Adolescents. Dept. of Hematology and Oncology. University Clinic Erlangen , Erlangen, Germany.
  • Schidlowski L; Division of Immunology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland; University of Zurich , Zurich, Switzerland.
  • Martínez de Saavedra Álvarez MT; Dept. of Paediatrics, BC Children's Hospital, University of British Columbia , Vancouver, Canada.
  • Alfaro R; Dept. of Paediatrics, BC Children's Hospital, University of British Columbia , Vancouver, Canada.
  • Rodríguez de Castro F; Dept. of Pediatrics, CHU St Pierre, ULB/VUB , Brussels, Belgium.
  • Meyts I; Clinical Immunology, Autoimmunity and Inflammation Laboratory, Faculty of Medicine and Pharmacy, Hassan II University , Casablanca, Morocco.
  • Hauck F; Dept. of Pediatric Infectious Diseases and Clinical Immunology, Ibn Rushd University Hospital , Casablanca, Morocco.
  • Puel A; Clinical Immunology, Autoimmunity and Inflammation Laboratory, Faculty of Medicine and Pharmacy, Hassan II University , Casablanca, Morocco.
  • Bastard P; Dept. of Translational Medical Sciences, Section of Pediatrics, Federico II University , Naples, Italy.
  • Boisson B; Dept. of Immunology, UGC Laboratories, University Hospital of Jaén , Jaén, Spain.
  • Jouanguy E; Study Group for Immune Dysfunction Diseases in Children, Institut de Recerca Sant Joan de Déu, Barcelona , Barcelona, Spain.
  • Abel L; Pediatric Infectious Diseases Unit, Hospital Sant Joan de Déu , Barcelona, Spain.
J Exp Med ; 220(5)2023 05 01.
Article in English | MEDLINE | ID: covidwho-2260121
ABSTRACT
X-linked recessive deficiency of TLR7, a MyD88- and IRAK-4-dependent endosomal ssRNA sensor, impairs SARS-CoV-2 recognition and type I IFN production in plasmacytoid dendritic cells (pDCs), thereby underlying hypoxemic COVID-19 pneumonia with high penetrance. We report 22 unvaccinated patients with autosomal recessive MyD88 or IRAK-4 deficiency infected with SARS-CoV-2 (mean age 10.9 yr; 2 mo to 24 yr), originating from 17 kindreds from eight countries on three continents. 16 patients were hospitalized six with moderate, four with severe, and six with critical pneumonia, one of whom died. The risk of hypoxemic pneumonia increased with age. The risk of invasive mechanical ventilation was also much greater than in age-matched controls from the general population (OR 74.7, 95% CI 26.8-207.8, P < 0.001). The patients' susceptibility to SARS-CoV-2 can be attributed to impaired TLR7-dependent type I IFN production by pDCs, which do not sense SARS-CoV-2 correctly. Patients with inherited MyD88 or IRAK-4 deficiency were long thought to be selectively vulnerable to pyogenic bacteria, but also have a high risk of hypoxemic COVID-19 pneumonia.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Myeloid Differentiation Factor 88 / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Child / Humans Language: English Year: 2023 Document Type: Article Affiliation country: Jem.20220170

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Myeloid Differentiation Factor 88 / COVID-19 Type of study: Prognostic study Topics: Long Covid Limits: Child / Humans Language: English Year: 2023 Document Type: Article Affiliation country: Jem.20220170